• Users Online: 179
  • Home
  • Print this page
  • Email this page
Home About us Editorial board Search Ahead of print Current issue Archives Submit article Instructions Subscribe Contacts Login 
ORIGINAL ARTICLE
Year : 2017  |  Volume : 45  |  Issue : 1  |  Page : 8-13

Study of therapeutic efficacy of percutaneous radiofrequency ablation versus percutaneous microwave ablation for hepatocellular carcinoma


1 Department of Internal Medicine, Faculty of Medicine, Tanta University, Tanta, Egypt
2 Department of Radiology, Faculty of Medicine, Tanta University, Tanta, Egypt

Correspondence Address:
Mohamed A Riad
Department of Internal Medicine, Faculty of Medicine, Tanta University, Tanta, 31512
Egypt
Login to access the Email id


DOI: 10.4103/tmj.tmj_45_16

Rights and Permissions

Background In the past two decades, thermal ablation therapy using energy sources has been increasingly accepted due to the advantages of greater capacity to devitalize hepatocellular carcinoma (HCC) with fewer treatment sessions. Among them, radiofrequency ablation (RFA) and microwave ablation (MWA) are the most commonly used modalities. Aim The aim of study was to compare RFA versus MWA in terms of therapeutic efficacy. Patients and methods This study included 130 patients proved to have HCC. They were divided into two groups. Group I included 70 patients who underwent RFA. Group II included 60 patients who underwent MWA. Results Comparison of complete ablation (CA), partial ablation (PA), local tumor progression (LTP), and distant recurrence was made between the two groups. The CA rate was 86.6% for the RF group and 91.6% for the MW group but without significance in lesions lower to 3 cm in diameter (P=0.7981). However, this difference was significant in lesions measuring 3.1–4 cm in diameter; the CA rate was 33.3% for the RF group and 85.7% for the MW group (P=0.0388). The PA rate was 13.3% for the RF group and 8.3% for the MW group but without significance in lesions lower to 3 cm in diameter (P=0.5843). However, this difference was statistically significant in lesions measuring 3.1–4 cm in diameter; the PA rate was 66.6% for the RF group and 14.2% for the MW group (P=0.0045). During the 18-month follow-up period for tumors lower to 3 cm in diameter of both groups, the LTP rate was 21% in the RF group and 13% in the MW group with a nonsignificant difference (P=0.1944), whereas for larger tumors (3.1–4 cm in diameter) the LTP rate was 33% in the RF group and 11% in the MW group with a significant difference (P=0.0387). Tumor distant recurrence was observed in 25 (41.6%) patients of the MW group and in 30 (42.8%) patients of the RF group with a nonsignificant difference (P=1.0000). Conclusion MW ablation is superior to RF ablation in HCC treatment, especially large one.


[FULL TEXT] [PDF]*
Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)
 

 Article Access Statistics
    Viewed143    
    Printed0    
    Emailed0    
    PDF Downloaded32    
    Comments [Add]    

Recommend this journal